Ocean Biomedical, Inc. Stock Nasdaq
Equities
OCEA
US67644P1057
Biotechnology & Medical Research
Sales 2021 | - | Sales 2022 | - | Capitalization | 110M 150M |
---|---|---|---|---|---|
Net income 2021 | -62M -84.59M | Net income 2022 | -17M -23.19M | EV / Sales 2021 | - |
Net Debt 2021 | 0.12 0.16 | Net Debt 2022 | 1.19 1.62 | EV / Sales 2022 | - |
P/E ratio 2021 |
-2.8
x | P/E ratio 2022 |
-10.5
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 28.01% |
1st Jan change | Capi. | |
---|---|---|
+8.38% | 115B | |
+13.04% | 107B | |
-13.56% | 22.31B | |
-3.99% | 21.6B | |
-5.62% | 18.23B | |
-39.93% | 17.62B | |
+7.51% | 14.26B | |
+33.73% | 12.37B | |
-28.32% | 8.28B |